WHO ICTRP trial
Diabetes specific formulae versus standard formulae as enteral nutrition to…
ACTRN12614000166673 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12614000166673 |
|---|---|
| Public title | Diabetes specific formulae versus standard formulae as enteral nutrition to treat hyperglycaemia in critically ill patients: study protocol for a randomised controlled feasibility trial |
| Scientific title | A randomised controlled feasibility trial to determine the efficacy of diabetes specific formulae to reduce exogenous insulin doses required to obtain acceptable glycaemic control when compared to the standard nutritional formula in critically ill tube fed patients |
| Primary sponsor | Mater Foundation and Mater Research Institute |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Critically ill tube fed ICU patients;Hyperglycemia; Critically ill tube fed ICU patients Hyperglycemia;Metabolic and Endocrine - Other metabolic disorders;Diet and Nutrition - Other diet and nutrition disorders |
| Interventions | Following consent participants will be randomised to the control (CHO 142g/L; 1.28kcal/mL), or the intervention, which is a low carbohydrate, low glycaemic index diabetes-specific formula (CHO 75g/L; 1kcal/mL), Once treatment allocation has… |
| Registration date | Nov 2, 2014 |
| Target size | 54 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: